Using a combination of the two drugs, several proteins associated with the basal subtype of bladder cancers were consistently decreased within both cell lines such as KRT1, KRT14, KRT16, P63, and TFAP2A. The gene discussed is KRT1; the disease is urinary bladder carcinoma.